ESLA biotech catalysts & pipeline

ESTRELLA IMMUNOPHARMA INC · Data as of 2026-09-08

Upcoming catalysts

1H2027

We anticipate completing the Phase II portion of the STARLIGHT-1 clinical trial in 1H2027.